Cardiovascular disease is a general term that refers to many different types of heart problems. Heart disease is the No. 1 ...

Lupin announced that it has launched Rivaroxaban tablets USP, 2.5 mg, in the US market following final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug ...

Lupin's shares increased by 21.51% over the past year. However, year-to-date (YTD), the stock has decreased by 14.21%. Over ...

A study published March 6 in The Lancet Regional Health - Americas highlights a growing divide in cardiovascular health in the U.S., showing that wealth and education play a significant role in heart ...